Professor Thozhukat Sathyapalan T.Sathyapalan@hull.ac.uk
Professor of Diabetes, Endocrinology and Metabolism
LCD SAFE
People Involved
Project Description
SAFE-LCD: Can the combination of continuous glucose monitoring and a digital low calorie diet programme make Type 2 diabetes remission achievable and safe in people on insulin therapy?
| Type of Project | Clinical Trial |
|---|---|
| Status | Project Complete |
| Funder(s) | Innovate UK |
| Value | £5,933.00 |
| Project Dates | Nov 1, 2022 - Apr 30, 2024 |
| This project contributes to the following UN Sustainable Development Goals |
|
You might also like
Esperion ETC 1002 Study Nov 1, 2016 - Mar 31, 2019
PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment Nov 1, 2016 - Oct 31, 2019
Primary objective:
To compare the effect of once-daily dosing of 14 mg oral semaglutide versus placebo, both in combination with metformin and/or sulfonylurea, basal insulin alone or metformin in combination with basal insulin on glycaemic control i...
Read More about PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment.
IVF Study 1: Does Insulin or Endocrine Disruptor levels affect fertility? Jan 1, 2014 - Dec 31, 2018